Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A

Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A

US Patent 11707536 · Granted Jul 25, 2023

Estimated economic value: $151,232,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII vari2024
Anti-factor IX padua antibodies2024
TFPI inhibitors and methods of use2023
Subcutaneous administration of ADAMTS132023
Gene therapy of hemophilia B using viral vectors encoding recombinant fix varian2023
Gene therapy of hemophilia B using viral vectors encoding recombinant fix varian2023
Nucleophilic catalysts for oxime linkage2023
Viral vectors encoding recombinant FVIII variants with increased expression for 2022
Viral vectors encoding recombinant FVIII variants with increased expression for 2022
Anti-MIF immunohistochemistry2022
Viral vectors encoding recombinant FVIII variants with increased expression for 2022
Viral vectors encoding recombinant FVIII variants with increased expression for 2022